| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-05 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.23 | 4e-05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.23 | 9e-05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |